# A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection

> **NCT00679497** · PHASE1 · COMPLETED · sponsor: **Juan A. Arnaiz** · enrollment: 30 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** MVA-B
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00679497
- **Lead sponsor:** Juan A. Arnaiz
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679497, "A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00679497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*